Neuroblastoma, Cancer research, Gene expression profiling, Bioinformatics and Survival analysis are his primary areas of study. His Neuroblastoma research includes themes of Internal medicine, microRNA, Kinase and Oncology. The Cancer research study combines topics in areas such as Cell growth, Cancer cell, Regulation of gene expression, Gene and N-Myc.
Matthias Fischer combines subjects such as RNA-Seq, Computational biology, Human genetics and Human genome with his study of Gene expression profiling. His research investigates the connection between RNA-Seq and topics such as Endpoint Determination that intersect with problems in Transcriptome. His Bioinformatics research is multidisciplinary, incorporating elements of Microarray and DNA microarray.
The scientist’s investigation covers issues in Neuroblastoma, Cancer research, Internal medicine, Gene and Bioinformatics. The N-Myc Proto-Oncogene Protein research Matthias Fischer does as part of his general Neuroblastoma study is frequently linked to other disciplines of science, such as Chemistry, therefore creating a link between diverse domains of science. His Cancer research study combines topics in areas such as Cellular differentiation, Apoptosis, N-Myc, Tumor progression and Regulation of gene expression.
His Internal medicine research incorporates themes from Endocrinology and Oncology. Matthias Fischer has researched Bioinformatics in several fields, including Microarray, DNA microarray, Cancer and Gene expression profiling. The study incorporates disciplines such as RNA-Seq and Survival analysis in addition to Gene expression profiling.
Matthias Fischer spends much of his time researching Neuroblastoma, Cancer research, Telomerase, Chemistry and Telomere. His primary area of study in Neuroblastoma is in the field of Childhood Neuroblastoma. His research in Cancer research intersects with topics in Phenotype, Suppressor, Downregulation and upregulation, Oncogene and Tumor progression.
His work carried out in the field of Telomerase brings together such families of science as Genetically engineered and Bioinformatics. His Telomere study deals with Cancer intersecting with Clinical trial. His Regulation of gene expression research focuses on Chromatin immunoprecipitation and how it relates to N-Myc, Signal transduction and Binding protein.
His primary areas of investigation include Neuroblastoma, Cancer research, Tumor progression, Chemistry and Genome. Matthias Fischer is interested in Mycn amplification, which is a field of Neuroblastoma. His Cancer research research incorporates elements of Chromatin, Binding protein, Regulation of gene expression and N-Myc.
His Tumor progression research integrates issues from Apoptosis, Mitochondrion, Mitochondrial ROS and Downregulation and upregulation. His study in Genome is interdisciplinary in nature, drawing from both Gene rearrangement, DNA, Transcriptome and Somatic cell. In the field of Genetics, his study on Extrachromosomal DNA, Extrachromosomal circular DNA and Telomere overlaps with subjects such as Cellular homeostasis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George.
Nature Genetics (2012)
The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Leming Shi;Gregory Campbell;Wendell D. Jones;Fabien Campagne.
Nature Biotechnology (2010)
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium
Zhenqiang Su;Paweł P. Łabaj;Sheng Li;Jean Thierry-Mieg.
Nature Biotechnology (2014)
Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles
Susanne Walz;Francesca Lorenzin;Jennifer Morton;Katrin E. Wiese.
Nature (2014)
Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Ina Oehme;Hedwig E. Deubzer;Dennis Wegener;Diana Pickert.
Clinical Cancer Research (2009)
Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification
André Oberthuer;Frank Berthold;Patrick Warnat;Barbara Hero.
Journal of Clinical Oncology (2006)
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Jan J Molenaar;Raquel Domingo-Fernández;Marli E Ebus;Sven Lindner.
Nature Genetics (2012)
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.
Gaurav Kumar Pandey;Sanhita Mitra;Santhilal Subhash;Falk Hertwig.
Cancer Cell (2014)
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.
Wenqian Zhang;Ying Yu;Falk Hertwig;Falk Hertwig;Jean Thierry-Mieg.
Genome Biology (2015)
Mutational dynamics between primary and relapse neuroblastomas
Alexander Schramm;Johannes Köster;Johannes Köster;Yassen Assenov;Kristina Althoff.
Nature Genetics (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Cologne
Charité - University Medicine Berlin
German Cancer Research Center
Ghent University
Fudan University
Charité - University Medicine Berlin
German Cancer Research Center
Ghent University
Ghent University
National Center for Toxicological Research
University of Naples Federico II
Gheorghe Asachi Technical University of Iași
Claude Bernard University Lyon 1
MSD (United States)
University of British Columbia
Polytechnique Montréal
Zhejiang University
University of California, San Francisco
University of Florida
Harvard University
Stellenbosch University
Sheba Medical Center
Oregon State University
Agricultural Research Service
University of Sussex
University of Paris-Saclay